CoChat

The efficacy and safety of probiotics in people with cancer: a systematic review

Open access
Redman, M.G., Ward, E.J., Phillips, R.S. · 2014 · Annals of Oncology

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Abstract

Background Probiotics are living microorganisms that are generally thought of as being beneficial to the recipient. They have been shown to be effective in people with acute infectious diarrhoea, and cost-effective in antibiotic-associated diarrhoea. Probiotics may have a role in people with cancer, as various cancer treatments often lead to diarrhoea. However, as people with cancer are often immunocompromised, it is important to assess for adverse events (AEs) such as infection, which could potentially be a consequence of deliberate ingestion of living microorganisms.Design A systematic review was carried out to collect, analyse and synthesise all available data on the efficacy and safety of probiotics in people with cancer (PROSPERO registration: CRD42012003454). Randomised, controlled trials, identified through screening multiple databases and grey literature, were included for analysing efficacy, while all studies were included for the analysis of safety of probiotics. Primary outcomes were the reduction in duration, severity and incidence of antibiotic-associated diarrhoea and chemotherapy-associated diarrhoea, and AEs, especially probiotic-associated infection. Where possible, data were combined for meta-analysis by a random-effects model, assessing causes of heterogeneity, including differences in strains, dosage and patient characteristics.Results Eleven studies (N = 1557 participants) were included for assessing efficacy. Results show that probiotics may reduce the severity and frequency of diarrhoea in patients with cancer and may reduce the requirement for anti-diarrhoeal medication, but more studies are needed to assess the true effect. For example comparing probiotic use to control 25 groups on effect on Common Toxicity Criteria ≥2 grade diarrhoea, odds ratio (OR) = 0.32 [95% confidence interval (CI) of 0.13-0.79; P = 0.01]. Seventeen studies (N = 1530) were included in the safety analysis. Five case reports showed probiotic-related bacteraemia/fungaemia/positive blood cultures.Conclusions Probiotics may be a rare cause of sepsis. Further evidence needs to be collated to determine whether probiotics provide a significant overall benefit for people with cancer.

Overview

Integrity signals

Registry

Crossref · 10.1093/annonc/mdu106

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 2

  1. Beckerson, 2012, Dietary advice during neutropenia. An update and consensus from the Haematology subgroup of the BDA Oncology Group, Complete Nutr, 12, 40
  2. Redman, 2012, The use of probiotics in people with cancer, PROSPERO

Cited by

See all 236

Metadata

Authors
Redman, M. G., Ward, E. J., & Phillips, R. S.
Affiliations
  • Hull York Medical School (GB)
  • Leeds General Infirmary (GB)
Corresponding author
Redman, M.G.
Venue
Annals of Oncology
Publisher
Elsevier BV
Published
2014-10
Volume
25
Issue
10
Pages
1919-1929
ISSN
0923-7534 (ISSN-L)
OpenAlex
W2149926230
Cited by
213
References
45
Citations by year
2026: 13 · 2025: 23 · 2024: 17 · 2023: 25 · 2022: 18 · 2021: 25 · 2020: 19 · 2019: 16 · 2018: 24 · 2017: 12 · 2016: 11 · 2015: 9 · 2014: 1
FWCI
1.36
Type
journal article
Language
en
Open access
Licence
Locations
  • Annals of Oncology (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
Keywords
probiotics, cancer patients, antibiotic-associated diarrhea, probiotic safety, sepsis, immunocompromised patients
MeSH terms
Cost-Benefit Analysis, Diarrhea, Humans, Neoplasms, Sepsis, Probiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.